Morgan Stanley (MS) 13D/13G Filings for Satsuma Pharmaceuticals, Inc. (STSA)

Morgan Stanley 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-04-09
4:50 pm
Sale
2021-03-3113GSatsuma Pharmaceuticals, Inc.
STSA
MORGAN STANLEY
MS
577,022
1.800%
-416,601decrease
(-41.93%)
Filing